Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma

In order to predict long-term prognosis and define individual treatment modalities for patients with oral squamous cell carcinoma (OSCC), more reliable tumor biomarkers are needed during the pretreatment workup period. The present study aimed to identify more reliable immunohistochemical tumor progn...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC oral health 2015-12, Vol.15 (1), p.153-153, Article 153
Hauptverfasser:	Lee, Hye-Jin, Kang, Young-Hoon, Lee, Jong-Sil, Byun, June-Ho, Kim, Uk-Kyu, Jang, Si-Jung, Rho, Gyu-Jin, Park, Bong-Wook
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Biomarkers, Tumor - metabolism Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - metabolism Dentistry Development and progression Gene Expression Regulation, Neoplastic Health aspects Homeopathy Humans Hyaluronan Receptors - metabolism Immunohistochemistry Materia medica and therapeutics Medical research Medicine, Experimental Metastasis Mouth Neoplasms - diagnosis Mouth Neoplasms - metabolism Nanog Homeobox Protein - metabolism Prognosis Squamous cell carcinoma Stem cells Therapeutics Tumor proteins Tumor Suppressor Protein p53 - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!